Experts Convene for Third Miami Cancer Institute Summit of the Americas on Immunotherapies for Hematologic Malignancies
MIAMI, FL – December 7, 2021–In the United States, approximately 186,400 people are expected to be diagnosed with leukemia, lymphoma, myeloma and other blood cancers this year, according to the American Cancer Society. Thousands more are already in treatment. In April 2022, the nation’s top experts will gather for the third Miami Cancer Institute Summit of Americas on Immunotherapies for Hematologic Malignancies to discuss the advances in immunologically and molecular based system therapies, new-targeted diagnostic and therapeutic strategies for lymphoma, myeloma and leukemia, the role and timing of hematopoietic cell transplantation and the latest on CAR – T cell therapies.
“The speed at which the field is advancing is very encouraging,” said symposium director Guenther Koehne, M.D., Ph.D., deputy director of Miami Cancer Institute, part of Baptist Health, and chief of Blood & Marrow Transplant and Hematologic Oncology and champion of the Summit. “But to maintain our forward progress we must not do our research in silos. We must share so that we can build upon what we have learned.”
The program is being held April 8 & 9, 2022, featuring a powerhouse faculty that includes physicians from Memorial Sloan Kettering, Harvard Medical School, Dana-Farber Cancer Institute, MD Anderson Cancer Center, Columbia University’s Herbert Irving Comprehensive Cancer Center, the Abramson Cancer Center at the University of Pennsylvania and other leading institutions. Approximately 300 physicians and other healthcare providers attended last year’s virtual Summit.
“Treatments are becoming more sophisticated and every day we are learning more about how to target treatment to the individual,” he said. “By discussing the most recent research, we move science forward, ultimately offering more options to patients and improving their outcomes.”
Miami Cancer Institute’s Blood and Marrow Transplantation program was launched in July of 2019. It hit the 100-patient milestone in just 18 months. In addition, in July of 2020, as the program continued to expand, Hope Tower opened on the Baptist Hospital campus, adjacent to the Institute. With 39 private rooms on 6 Hope and 45 private rooms on 5 Hope dedicated tor bone marrow and immunotherapy patients, the new facility gives patients who face lengthy hospital stays because of their compromised immune systems a spacious accommodation that includes a refrigerator, microwave, large bathroom and even room to exercise.
At the Summit, Dr. Koehne will share his research and the Institute’s experience. To register, or for more information go to https://cmeonline.baptisthealth.net/immunotherapy-symposium.
About Miami Cancer Institute
Miami Cancer Institute brings to South Florida access to personalized clinical treatments and comprehensive support services delivered with unparalleled compassion. No other cancer program in the region has the combination of cancer-fighting expertise and advanced technology—including the first proton therapy center in South Florida, Latin America and the Caribbean, and one of the only radiation oncology programs in the world with each of the newest radiation therapies in one place—to diagnose and deliver precise cancer treatments that achieve the best outcomes and improve the lives of cancer patients. The Institute offers an impressive roster of established community oncologists and renowned experts, clinical researchers and genomic scientists recruited from the nation’s top cancer centers. Selected as Florida’s only member of the Memorial Sloan Kettering Cancer (MSK) Alliance, Miami Cancer Institute is part of a meaningful clinical collaboration that affords patients in South Florida access to innovative treatments and ensures that the standards of care developed by their multidisciplinary disease management teams match those at MSK.
Miami Cancer Institute is part of Baptist Health South Florida, the largest healthcare organization in the region, with 12 hospitals, more than 24,000 employees, 4,000 physicians and 100 outpatient centers, urgent care facilities and physician practices spanning across Miami-Dade, Monroe, Broward and Palm Beach counties. Baptist Health has internationally renowned centers of excellence in cancer, cardiovascular care, orthopedics and sports medicine, and neurosciences. In addition, it includes Baptist Health Medical Group; Baptist Health Quality Network; and Baptist Health Care On Demand, a virtual health platform. A not-for-profit organization supported by philanthropy and committed to its faith-based charitable mission of medical excellence, Baptist Health has been recognized by Fortune as one of the 100 Best Companies to Work For in America and by Ethisphere as one of the World’s Most Ethical Companies. For more information, visit BaptistHealth.net/Newsroom and connect with us on Facebook, Instagram, Twitter and LinkedIn.
# # #
